HilleVax halts development of world’s most advanced norovirus vaccine after phase 2 failure 11-Jul-2024 By Clara Rodriguez Ferndandez Results from the NEST-IN1 trial have shown that HilleVax’s vaccine candidate was ineffective at preventing norovirus infections in infants.